Načítá se...
Improving Quality of Patient Data for Treatment of Multidrug- or Rifampin-Resistant Tuberculosis
International policy for treatment of multidrug- and rifampin-resistant tuberculosis (MDR/RR TB) relies largely on individual patient data (IPD) from observational studies of patients treated under routine conditions. We prepared guidance on which data to collect and what measures could improve cons...
Uloženo v:
| Vydáno v: | Emerg Infect Dis |
|---|---|
| Hlavní autoři: | , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Centers for Disease Control and Prevention
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7045826/ https://ncbi.nlm.nih.gov/pubmed/31922953 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2603.190997 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|